Showing results (131-140 of 228) with videos related to
Sort By:
Pageof 23
Journal of Neurochemistry|January 1, 1988
Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agentsW D Rausch, Y Hirata, T Nagatsu, et al.Journal of Neurochemistry|March 1, 1991
Selective increase of iron in substantia nigra zona compacta of parkinsonian brainsE Sofic, W Paulus, K Jellinger, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's diseaseK Jellinger, L Linert, E Kienzl, et al.Journal of Neural Transmission|January 1, 1978
Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administrationG P Reynolds, P Riederer, M Sandler, et al.Journal of Neural Transmission. Supplementum|January 1, 1978
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathiesP Riederer, W D Rausch, W Birkmayer, et al.Archives of Neurology|August 26, 1998
Pharmacological therapy in progressive supranuclear palsyK Kompoliti, C G Goetz, I Litvan, et al.Acta Neuropathologica|January 1, 1984
Metastasis of solid tumors in extraocular musclesR Weiss, W Grisold, K Jellinger, et al.Journal of Neurology|January 1, 1980
Symptomatology of the most severe form of tuberculous meningitisF Gerstenbrand, K Jellinger, E Maida, et al.Neuroscience|September 1, 1988
Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stemC Konradi, E Svoma, K Jellinger, et al.Liver|August 1, 1988
Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathyP Ferenci, P Riederer, K Jellinger, et al.Pageof 23